Katz, M., Varadhachary, G., Fleming, J., Wolff, R., Lee, J., Pisters, P., . . . Evans, D. (2010). Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Katz, Matthew, et al. Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation. 2010.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Katz, Matthew, et al. Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation. 2010.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.